Features of cancer management in obese patients

Critical Reviews in Oncology/Hematology

Volumn 85, Issue 2, 2013, Pages 193-205

  Hijazi, Hussam ^a   Magné, Nicolas ^b   Levy, Antonin ^c   Marcy, Pierre Yves ^a   Lacout, Alexis ^d   Leysalle, Axel ^a   Hannoun Levi, Jean Michel ^a   Schneider, Stephane ^e   Sadoul, Jean Louis ^f   Thariat, Juliette ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b INSTITUT DE CANCÉROLOGIE LUCIEN NEUWIRTH   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Imaging Centre   (France)

^e UNIVERSITY HOSPITAL OF NICE   (France)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Adaptation limitation; Bariatric; Cancer risk; Incidence; Obese; Overweight; Technical; Toxicity; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PACLITAXEL; TROXACITABINE;

BODY MASS; BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CAUSE OF DEATH; CHILD; COMORBIDITY; DIAGNOSTIC IMAGING; DRUG CLEARANCE; DRUG OVERDOSE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; OBESITY; ONCOLOGY; PREDICTION; PREVALENCE; RADIATION DOSE; REVIEW; UNITED STATES; WEIGHT GAIN;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; NEOPLASMS; OBESITY; PROGNOSIS; RADIOTHERAPY; SIGNAL TRANSDUCTION;

EID: 84872594400     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2012.06.003     Document Type: Review

References (96)

1. Bianchini F., Kaaks R., Vainio H. Overweight, obesity, and cancer risk. Lancet Oncology 2002, 3(9):565-574.
2. Rogers P.C., Meacham L.R., Oeffinger K.C., Henry D.W., Lange B.J. Obesity in pediatric oncology. Pediatric Blood and Cancer 2005, 45(7):881-891.
3. Berenson G.S. Health consequences of obesity. Pediatric Blood and Cancer 2012, 58(1):117-121.
4. Wolin K.Y., Carson K., Colditz G.A. Obesity and cancer. Oncologist 2010, 15(6):556-565.
5. Hyde R. Europe battles with obesity. Lancet 2008, 371(9631):2160-2161.
6. Renehan A.G., Roberts D.L., Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Archives of Physiology and Biochemistry 2008, 114(1):71-83.
7. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 2003, 348(17):1625-1638.
8. Department of Health and Human Services Ws Overweight and obesity: obesity trends - 1991-2001. Prevalence of obesity among U.S. adults by state 2001, Centers for Disease Control and Prevention.
9. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Journal of the American Medical Association 2003, 289(1):76-79.
10. Polednak A.P. Trends in incidence rates for obesity-associated cancers in the US. Cancer Detection and Prevention 2003, 27(6):415-421.
11. Reynolds J.V., Donohoe C.L., Doyle S.L. Diet, obesity and cancer. Irish Journal of Medical Science 2011, 180(2):521-527.
12. Uppot R.N. Impact of obesity on radiology. Radiologic Clinics of North America 2007, 45(2):231-246.
13. Guest A.R., Helvie M.A., Chan H.P., Hadjiiski L.M., Bailey J.E., Roubidoux M.A. Adverse effects of increased body weight on quantitative measures of mammographic image quality. American Journal of Roentgenology 2000, 175(3):805-810.
14. Yanch J.C., Behrman R.H., Hendricks M.J., McCall J.H. Increased radiation dose to overweight and obese patients from radiographic examinations. Radiology 2009, 252(1):128-139.
15. Schindera S.T., Nelson R.C., Lee E.R., Delong D.M., Ngyen G., Toncheva G., et al. Abdominal multislice CT for obese patients: effect on image quality and radiation dose in a phantom study. Academic Radiology 2007, 14(4):486-494.
16. Masuda Y., Kondo C., Matsuo Y., Uetani M., Kusakabe K. Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose. Journal of Nuclear Medicine 2009, 50(6):844-848.
17. Mansfield P.F., Hohn D.C., Fornage B.D., Gregurich M.A., Ota D.M. Complications and failures of subclavian-vein catheterization. New England Journal of Medicine 1994, 331(26):1735-1738.
18. Marcy P.Y., Magne N., Castadot P., Italiano A., Amoretti N., Bailet C., et al. Is radiologic placement of an arm port mandatory in oncology patients? Analysis of a large bi-institutional experience. Cancer 2007, 110(10):2331-2338.
19. Bach F., Videbaek C., Holst-Christensen J., Boesby S. Cytostatic extravasation. A serious complication of long-term venous access. Cancer 1991, 68(3):538-539.
20. Khorana A.A., Francis C.W., Culakova E., Fisher R.I., Kuderer N.M., Lyman G.H. Thromboembolism in hospitalized neutropenic cancer patients. Journal of Clinical Oncology 2006, 24(3):484-490.
21. De Martino R.R., Goodney P.P., Spangler E.L., Wallaert J.B., Corriere M.A., Rzucidlo E.M., et al. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. Journal of Vascular Surgery 2012, 55(4):1035-10400000.
22. Meyerhardt J.A., Tepper J.E., Niedzwiecki D., Hollis D.R., McCollum A.D., Brady D., et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. Journal of Clinical Oncology 2004, 22(4):648-657.
23. Chern H., Chou J., Donkor C., Shia J., Guillem J.G., Nash G.M., et al. Effects of obesity in rectal cancer surgery. Journal of the American College of Surgeons 2010, 211(1):55-60.
24. Makino T., Shukla P.J., Rubino F., Milsom J.W. The impact of obesity on perioperative outcomes after laparoscopic colorectal resection. Annals of Surgery 2012, 255(2):228-236.
25. Scheidbach H., Benedix F., Hügel O., Kose D., Köckerling F., Lippert H. Laparoscopic approach to colorectal procedures in the obese patient: risk factor or benefit?. Obesity Surgery 2008, 18:66-70.
26. Mitsuyama H., Wallner K.E., Merrick G.S. Treatment of prostate cancer in obese patients. Oncology (Williston Park) 2006, 20(10):1191-1197. [discussion 8, 206, 208].
27. Skolarus T.A., Wolin K.Y., Grubb R.L. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer. Nature Clinical Practice Urology 2007, 4(11):605-614.
28. Freedland S.J., Aronson W.J., Kane C.J., Presti J.C., Amling C.L., Elashoff D., et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. Journal of Clinical Oncology 2004, 22(3):446-453.
29. Amling C.L., Riffenburgh R.H., Sun L., Moul J.W., Lance R.S., Kusuda L., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. Journal of Clinical Oncology 2004, 22(3):439-445.
30. Sandhu J.S., Gotto G.T., Herran L.A., Scardino P.T., Eastham J.A., Rabbani F. Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy. Journal of Urology 2011, 185(6):2148-2152.
31. Montgomery J.S., Gayed B.A., Hollenbeck B.K., Daignault S., Sanda M.G., Montie J.E., et al. Obesity adversely affects health related quality of life before and after radical retropubic prostatectomy. Journal of Urology 2006, 176(1):257-261. [discussion 61-2].
32. Freedland S.J. Obesity and prostate cancer: a growing problem. Clinical Cancer Research 2005, 11(19 Pt 1):6763-6766.
33. Caquant F., Mas-Calvet M., Turbelin C., Lesoin A., Lefebvre D., Narducci F., et al. Endometrial cancer by laparoscopy and vaginal approach in the obese patient. Bull Cancer 2006, 93(4):402-406.
34. Chang D.W., Wang B., Robb G.L., Reece G.P., Miller M.J., Evans G.R., et al. Effect of obesity on flap and donor-site complications in free transverse rectus abdominis myocutaneous flap breast reconstruction. Plastic and Reconstructive Surgery 2000, 105(5):1640-1648.
35. Pinsolle V., Grinfeder C., Mathoulin-Pelissier S., Faucher A. Complications analysis of 266 immediate breast reconstructions. Journal of Plastic, Reconstructive and Aesthetic Surgery 2006, 59(10):1017-1024.
36. Werner R.S., McCormick B., Petrek J., Cox L., Cirrincione C., Gray J.R., et al. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 1991, 180(1):177-184.
37. Hanley M.J., Abernethy D.R., Greenblatt D.J. Effect of obesity on the pharmacokinetics of drugs in humans. Clinical Pharmacokinetics 2010, 49(2):71-87.
38. Gurney H., Shaw R. Obesity in dose calculation: a mouse or an elephant?. Journal of Clinical Oncology 2007, 25(30):4703-4704.
39. Dignam J.J., Polite B.N., Yothers G., Raich P., Colangelo L., O'Connell M.J., et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. Journal of the National Cancer Institute 2006, 98(22):1647-1654.
40. Ramos Chaves M., Boleo-Tome C., Monteiro-Grillo I., Camilo M., Ravasco P. The diversity of nutritional status in cancer: new insights. Oncologist 2010, 15(5):523-530.
41. Griggs J.J., Sorbero M.E., Lyman G.H. Undertreatment of obese women receiving breast cancer chemotherapy. Archives of Internal Medicine 2005, 165(11):1267-1273.
42. Dignam J.J., Wieand K., Johnson K.A., Raich P., Anderson S.J., Somkin C., et al. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Research and Treatment 2006, 97(3):245-254.
43. Rosner G.L., Hargis J.B., Hollis D.R., Budman D.R., Weiss R.B., Henderson I.C., et al. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. Journal of Clinical Oncology 1996, 14(11):3000-3008.
44. Colleoni M., Li S., Gelber R.D., Price K.N., Coates A.S., Castiglione-Gertsch M., et al. Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index. Lancet 2005, 366(9491):1108-1110.
45. Griggs J.J., Culakova E., Sorbero M.E., van Ryn M., Poniewierski M.S., Wolff D.A., et al. Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. Journal of Clinical Oncology 2007, 25(3):277-284.
46. Sparreboom A., Wolff A.C., Mathijssen R.H., Chatelut E., Rowinsky E.K., Verweij J., et al. Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese. Journal of Clinical Oncology 2007, 25(30):4707-4713.
47. Georgiadis M.S., Steinberg S.M., Hankins L.A., Ihde D.C., Johnson B.E. Obesity and therapy-related toxicity in patients treated for small-cell lung cancer. Journal of the National Cancer Institute 1995, 87(5):361-366.
48. Griggs J.J., Mangu P.B., Anderson H., Balaban E.P., Dignam J.J., Hryniuk W.M., et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American society of clinical oncology clinical practice guideline. Journal of Clinical Oncology 2012, 30(May (13)):1553-1561.
49. Prado C.M., Lieffers J.R., McCargar L.J., Reiman T., Sawyer M.B., Martin L., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncology 2008, 9(7):629-635.
50. Herrington J.D., Tran H.T., Riggs M.W. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia. Cancer Chemotherapy and Pharmacology 2006, 57(2):241-247.
51. Martra F., Kunos C., Gibbons H., Zola P., Galletto L., DeBernardo R., et al. Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study. American Journal of Obstetrics and Gynecology 2008, 198(1). 89 e1-8.
52. Davies B.J., Walsh T.J., Ross P.L., Knight S.J., Sadetsky N., Carroll P.R., et al. Effect of BMI on primary treatment of prostate cancer. Urology 2008, 72(2):406-411.
53. Deneuve S., Tan H.K., Eghiaian A., Temam S. Management and outcome of head and neck squamous cell carcinomas in obese patients. Oral Oncology 2011, 47(7):631-635.
54. Palma D., Pickles T., Tyldesley S. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer. BJU International 2007, 100(2):315-319.
55. Zilli T., Nguyen T.V., Bahary J.P., Chagnon M., Dufresne A., Taussky D. Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy. International Journal of Obesity (London) 2011, 35(11):1421-1426.
56. Wong J.R., Gao Z., Merrick S., Wilson P., Uematsu M., Woo K., et al. Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1465 computed tomographic images. International Journal of Radiation Oncology, Biology, Physics 2009, 75(1):49-55.
57. Jacobson B.C., Somers S.C., Fuchs C.S., Kelly C.P., Camargo C.A. Body-mass index and symptoms of gastroesophageal reflux in women. New England Journal of Medicine 2006, 354(22):2340-2348.
58. Rockhill J., Wallner K., Hoffman C., Merrick G., Simpson C., Arthurs S. Prostate brachytherapy in obese patients. Brachytherapy 2002, 1(1):54-60.
59. Kubo H. Use of oblique simulation films for estimating the maximum dose to the bladder and rectum in obese brachytherapy patients. Medical Physics 1995, 22(4):441-442.
60. Sweigart K.D. A simple method of alignment for pelvic irradiation in obese patients. Medical Dosimetry 2002, 27(4):269-270.
61. Mohiuddin M.M., Zhang B., Tkaczuk K., Khakpour N. Upright, standing technique for breast radiation treatment in the morbidly obese patient. Breast Journal 2010, 16(4):448-450.
62. Bergom C., Kelly T., Morrow N., Wilson J.F., Walker A., Xiang Q., et al. Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts. International Journal of Radiation Oncology, Biology, Physics 2011, 83(3):821-828.
63. Kirby A.M., Evans P.M., Helyer S.J., Donovan E.M., Convery H.M., Yarnold J.R. A randomised trial of supine versus prone breast radiotherapy (SuPr study): comparing set-up errors and respiratory motion. Radiotherapy and Oncology 2011, 100(2):221-226.
64. Lin L.L., Hertan L., Rengan R., Kevin Teo B.K. Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. International Journal of Radiation Oncology, Biology, Physics 2011, 83(2):670-675.
65. Keshtgar M.R., Vaidya J.S., Tobias J.S., Wenz F., Joseph D., Stacey C., et al. Targeted intraoperative radiotherapy for breast cancer in patients in whom external beam radiation is not possible. International Journal of Radiation Oncology, Biology, Physics 2011, 80(1):31-38.
66. Carmichael A.R., Bates T. Obesity and breast cancer: a review of the literature. Breast 2004, 13(2):85-92.
67. Patil N., Crook J., Saibishkumar E.P., Aneja M., Borg J., Pond G., et al. The effect of obesity on rectal dosimetry after permanent prostate brachytherapy. Brachytherapy 2009, 8(2):218-222.
68. Freedland S.J., Sun L., Kane C.J., Presti J.C., Terris M.K., Amling C.L., et al. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU International 2008, 102(8):969-974.
69. Welsh J., Thomas J., Shah D., Allen P.K., Wei X., Mitchell K., et al. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2011, 81(1):91-96.
70. Heinzerling J.H., Papiez L., Chien S., Anderson J., Forster K., Zhang G., et al. Stereotactic body radiation therapy: evaluation of setup accuracy and targeting methods for a new couch integrated immobilization system. Technology in Cancer Research and Treatment 2008, 7(3):197-206.
71. Sterzing F., Schubert K., Sroka-Perez G., Kalz J., Debus J., Herfarth K. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlentherapie und Onkologie 2008, 184(1):8-14.
72. Ramsey C.R., Scaperoth D., Seibert R., Chase D., Byrne T., Mahan S. Image-guided helical tomotherapy for localized prostate cancer: technique and initial clinical observations. Journal of Applied Clinical Medical Physics 2007, 8(3):2320.
73. Kirby A.M., Evans P.M., Donovan E.M., Convery H.M., Haviland J.S., Yarnold J.R. Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry. Radiotherapy and Oncology 2010, 96(2):178-184.
74. Varga Z., Hideghety K., Mezo T., Nikolenyi A., Thurzo L., Kahan Z. Individual positioning: a comparative study of adjuvant breast radiotherapy in the prone versus supine position. International Journal of Radiation Oncology, Biology, Physics 2009, 75(1):94-100.
75. Patel R.R., Becker S.J., Das R.K., Mackie T.R. A dosimetric comparison of accelerated partial breast irradiation techniques: multicatheter interstitial brachytherapy, three-dimensional conformal radiotherapy, and supine versus prone helical tomotherapy. International Journal of Radiation Oncology, Biology, Physics 2007, 68(3):935-942.
76. Woody N.M., Videtic G.M., Stephans K.L., Djemil T., Kim Y., Xia P. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes. International Journal of Radiation Oncology, Biology, Physics 2011, 83(1):427-434.
77. Roberts D.L., Dive C., Renehan A.G. Biological mechanisms linking obesity and cancer risk: new perspectives. Annual Review of Medicine 2010, 61:301-316.
78. Khandekar M., Cohen P., Spiegelman B. Molecular mechanisms of cancer development in obesity. Nature Reviews Cancer 2011, 24(1112):886-895. 10.1038/nrc3174.
79. Gove M.E., Sherry C.L., Pini M., Fantuzzi G. Generation of leptin receptor bone marrow chimeras: recovery from irradiation, immune cellularity, cytokine expression, and metabolic parameters. Obesity (Silver Spring) 2010, 18(12):2274-2281.
80. Banks A.S., Davis S.M., Bates S.H., Myers M.G. Activation of downstream signals by the long form of the leptin receptor. Journal of Biological Chemistry 2000, 275(19):14563-14572.
81. Kanai M., Konda Y., Nakajima T., Izumi Y., Kanda N., Nanakin A., et al. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway. Oncogene 2003, 22(4):548-554.
82. Cong L., Chen K., Li J., Gao P., Li Q., Mi S., et al. Regulation of adiponectin and leptin secretion and expression by insulin through a PI3K-PDE3B dependent mechanism in rat primary adipocytes. Biochemical Journal 2007, 403(3):519-525.
83. Holland W.L., Miller R.A., Wang Z.V., Sun K., Barth B.M., Bui H.H., et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature Medicine 2011, 17(1):55-63.
84. Nomura D.K., Long J.Z., Niessen S., Hoover H.S., Ng S.W., Cravatt B.F. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 2010, 140(1):49-61.
85. Nguyen P.L., Ma J., Chavarro J.E., Freedman M.L., Lis R., Fedele G., et al. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. Journal of Clinical Oncology 2010, 28(25):3958-3964.
86. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003, 112(12):1796-1808.
87. Park E.J., Lee J.H., Yu G.Y., He G., Ali S.R., Holzer R.G., et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010, 140(2):197-208.
88. Rothwell P.M., Fowkes F.G., Belch J.F., Ogawa H., Warlow C.P., Meade T.W. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011, 377(9759):31-41.
89. Burnet N.G., Elliott R.M., Dunning A., West C.M. Radiosensitivity, radiogenomics and RAPPER. Clinical Oncology (Royal College of Radiologists) 2006, 18(7):525-528.
90. Ahn J., Ambrosone C.B., Kanetsky P.A., Tian C., Lehman T.A., Kropp S., et al. Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clinical Cancer Research 2006, 12(23):7063-7070.
91. Tan X.L., Popanda O., Ambrosone C.B., Kropp S., Helmbold I., von Fournier D., et al. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Research and Treatment 2006, 97(3):255-262.
92. Chang-Claude J., Ambrosone C.B., Lilla C., Kropp S., Helmbold I., von Fournier D., et al. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. British Journal of Cancer 2009, 100(10):1680-1686.
93. Chang-Claude J., Popanda O., Tan X.L., Kropp S., Helmbold I., von Fournier D., et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clinical Cancer Research 2005, 11(13):4802-4809.
94. Barnett G.C., Coles C.E., Elliott R.M., Baynes C., Luccarini C., Conroy D., et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncology 2012, 13(1):65-77.
95. Jacquelin-Ravel N., Pichard C. Clinical nutrition, body composition and oncology: a critical literature review of the synergies. Critical Reviews in Oncology/Hematology April 2012, [Epub ahead of print].
96. Brinksma A., Huizinga G., Sulkers E., Kamps W., Roodbol P., Tissing W. Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Critical Reviews in Oncology/Hematology January 2012, [Epub ahead of print].